✦ LIBER ✦

Commerically avallable herbal preparation and its modified dispense in patients with functional dyspepsia. Results of a double-blind, placebo-controlled, randomized multicenter trial

✍ Scribed by Madisch, Ahmed; Melderis, Hans; Mayr, Gunthild; Sassin, Irena; Hotz, Juergen

Book ID: 124124839
Publisher: Elsevier Science
Year: 2001
Tongue: English
Weight: 153 KB
Volume: 120
Category: Article
ISSN: 0016-5085
DOI: 10.1016/S0016-5085(08)81172-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Benefit of a herbal preparation in patie

Benefit of a herbal preparation in patients with irritable bowel syndrome: Results of a double-blind, randomized, placebo-controlled multicenter trial

✍ Madisch, Ahmed; Plein, Klaus; Mayr, Gunthild; Buchert, Dagobert; Hotz, Juergen 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 182 KB

Randomized, double-blind, placebo-contro

Randomized, double-blind, placebo-controlled crossover trial of famotidine in patients with functional dyspepsia

✍ M. Kato; M. Watanabe; S. Konishi; M. Kudo; J. Konno; T. Meguro; S. Kitamori; S. 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 78 KB

Herbal preparations in patients with irr

Herbal preparations in patients with irritable bowel syndrome: Results of a double-blin, randomized, placebo-controlled multicenter trial

✍ Ahmed Madisch; Gerald Holtmann; Irena Sassin; Klaus Plein; Gunthild Mayr; Juerge 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 211 KB

Efficacy of a herbal preparation in pati

Efficacy of a herbal preparation in patients with functional dyspepsia: A meta-analysis of double-blind, randomized, clinical trials

✍ Karl-Josef Gundermann; Erhard Godehardt; Marianne Ulbrich 📂 Article 📅 2003 🏛 Springer Healthcare Communications 🌐 English ⚖ 97 KB

Rituximab in patients with primary progr

Rituximab in patients with primary progressive multiple sclerosis: Results of a randomized double-blind placebo-controlled multicenter trial

✍ Kathleen Hawker; Paul O'Connor; Mark S. Freedman; Peter A. Calabresi; Jack Antel 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 158 KB 👁 2 views

## Abstract ## Objective Rituximab, a monoclonal antibody selectively depleting CD20+ B cells, has demonstrated efficacy in reducing disease activity in relapsing‐remitting multiple sclerosis (MS). We evaluated rituximab in adults with primary progressive MS (PPMS) through 96 weeks and safety thro

M1802 Herbal Preparation STW 5 Improved

M1802 Herbal Preparation STW 5 Improved Quality of Life in Patients with Functional Dyspepsia - Results of a Placebo-Controlled Trial

✍ Madisch, Ahmed; von Arnim, Ulrike; Müller, Jürgen; Vinson, Bettina R.; Zeller, K 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 96 KB